Will cannabis rescheduling affect drug testing...

*Lawmakers push for more marijuana reform; MA anti-cannabis ballot
signatures; NJ psilocybin vote; Poll: Americans use marijuana for holiday
stress*

Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Your support makes Marijuana Moment possible…*

*BREAKING*: Journalism is often consumed for free, but costs money to
produce! While this newsletter is proudly sent without cost to you, our
ability to send it each day depends on the financial support of readers who
can afford to give it. So if you’ve got a few dollars to spare each month
and believe in the work we do, please consider joining us on Patreon today.
https://www.patreon.com/marijuanamoment

*/ TOP THINGS TO KNOW*

The U.S. Department of Transportation sent a notice clarifying that
President Donald Trump’s marijuana rescheduling executive order “will not
change” federal drug testing process and regulations for safety‐sensitive
transportation workers—at least “until any rescheduling is complete.”

Bipartisan members of Congress say that President Donald Trump’s marijuana
rescheduling order is only the first step toward needed reforms—and that
cannabis industry banking access, sentencing reform and full legalization
should follow.

The Massachusetts Secretary of the Commonwealth’s Elections Division
certified that a campaign to scale back the marijuana legalization law by
recriminalizing recreational sales and home grow got enough signatures to
advance its initiative toward the 2026 ballot.

The New Jersey Assembly Appropriations Committee approved a bill to
legalize psilocybin therapy and create a regulated program for patient
access.

A new poll shows that nearly one in three Americans “pre-game” with
marijuana before family holiday gatherings to emotionally prepare and deal
with stress.

*/ FEDERAL*

A Department of Veterans Affairs spokesperson said marijuana rescheduling
won’t allow the agency’s doctors to prescribe medical cannabis but will
make it easier to conduct research on marijuana.

Former Deputy Assistant Secretary of Defense for Counternarcotics and
Stabilization Policy James Saenz co-authored an op-ed criticizing the Trump
administration’s military strikes on alleged drug boats.

Sen. Cynthia Lummis (R-WY) said she disagrees with President Donald Trump
on marijuana rescheduling.

Sen. Tom Cotton (R-AR) and Rep. Andy Harris (R-MD) praised the recently
approved federal recriminalization of hemp THC products.

Rep. Pete Sessions (R-TX) said the White House rejected his request for a
meeting with President Donald Trump to express his concerns about marijuana
rescheduling.

Rep. Greg Steube (R-FL) discussed the benefits of rescheduling marijuana.

Former Rep. Matt Gaetz (R-FL) said President Donald Trump “delivered” on
marijuana rescheduling when “Obama couldn’t get it done” and “Biden
couldn’t get it done.”

*/ STATES*

California’s attorney general touted efforts to eradicate illegal marijuana
plants. Separately, regulators announced a recall of marijuana products due
to the company operating as a distributor without a distributor license.

A Pennsylvania representative said she is “not going to ever support
legalization of recreational marijuana.”

Arizona regulators filed changes to marijuana rules.

Illinois regulators are proposing changes to marijuana dispensary rules.

Colorado regulators published a bulletin about burglaries against marijuana
businesses.

Oklahoma regulators published guidance about requirements for physicians
who want to recommend medical cannabis.

Michigan regulators signed a cannabis compact with the Pokagon Band of
Potawatomi Indians of Michigan and Indiana.

Texas officials awarded $50 million to UTHealth Houston and the University
of Texas Medical Branch at Galveston to support ibogaine therapy trials.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

*/ SCIENCE & HEALTH*

A review concluded that “CBD is a valuable antioxidant agent in skin care
science.”

A study found that “cognitive performance improved two weeks after
receiving psilocybin-assisted psychotherapy.”

*/ ADVOCACY, OPINION & ANALYSIS*

Former Republican National Committee Communications Director Kevin Heye
said President Donald Trump’s marijuana rescheduling order sends a “mixed
message.”

The Heritage Foundation criticized President Donald Trump’s move to
reschedule marijuana.

Gun Owners of America tweeted, “President Trump just ordered that marijuana
be reclassified from Schedule I to Schedule III. GOA is calling on ATF to
cease treating Americans who are prescribed marijuana as ‘unlawful users of
controlled substances’ & federally prohibited from possessing firearms.”

*/ BUSINESS*

Atai Beckley N.V. received a U.S. patent for its oral R-MDMA medication.

Canadian retailers sold C$451.7 million worth of legal marijuana products
in October.

*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Photo courtesy of Mike Latimer.*

The post Will cannabis rescheduling affect drug testing for
safety-sensitive workers? (Newsletter: December 23, 2025) appeared first on Marijuana
Moment.